19:30 IST
NSE
Annual General Meeting
Curis Lifesciences Annual General Meeting
Curis Lifesciences filed its 10th AGM notice and FY 2025-26 Annual Report. The meeting is scheduled for September 29, 2026.
Curis Lifesciences Ltd
- Share price
- ₹202.00
- Market cap
- ₹163.3 Cr
- Revenue (annual)
- ₹60.63 Cr
- Net profit (annual)
- ₹6.92 Cr
- P/E (TTM)
- 23.6×Sector 47.3×
- Promoter holding
- 68.03%
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 1Merger & Restructuring 1Management Change 1Board Meeting Outcome 1Annual General Meeting 1
Time
5 announcements with these filters
19:00 IST
NSE
Board Meeting Outcome
Curis Lifesciences Board Meeting Outcome
Curis Lifesciences Limited approved the Director's Report, related party transactions, and scheduled its 10th Annual General Meeting for September 29, 2026. Board outcomes were finalized.
19:12 IST
NSE
Management Change
Curis Lifesciences Management Change
Curis Lifesciences Limited announced the resignation of Mr. Nikhil Purohit as Company Secretary and Compliance Officer, effective September 3, 2026.
19:11 IST
NSE
Other Announcement
Curis Lifesciences Other Announcement
Curis Lifesciences Limited submitted the RTA confirmation certificate for the quarter ended June 30, 2026, as required under SEBI Regulation 74(5).
19:01 IST
NSE
Merger & Restructuring
Curis Lifesciences Merger & Restructuring Worth ₹0.05 Cr
Curis Lifesciences Limited has acquired a 49.95% stake in CUROSUN PHARMACEUTICAL NIG LTD, Nigeria, for Rs. 5 Lakhs to expand its pharmaceutical market presence.
- Value
- ₹0.05 Cr